↓ Skip to main content

A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management

Overview of attention for article published in Frontiers in Pharmacology, February 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter
16 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
185 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management
Published in
Frontiers in Pharmacology, February 2021
DOI 10.3389/fphar.2021.576448
Pubmed ID
Authors

Muhammad Harris Shoaib, Farrukh Rafiq Ahmed, Muhammad Sikandar, Rabia Ismail Yousuf, Muhammad Talha Saleem

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 185 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 185 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 12%
Student > Bachelor 19 10%
Researcher 15 8%
Student > Postgraduate 9 5%
Professor 7 4%
Other 23 12%
Unknown 90 49%
Readers by discipline Count As %
Medicine and Dentistry 40 22%
Nursing and Health Professions 17 9%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Immunology and Microbiology 5 3%
Biochemistry, Genetics and Molecular Biology 4 2%
Other 19 10%
Unknown 94 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2022.
All research outputs
#3,783,452
of 23,929,753 outputs
Outputs from Frontiers in Pharmacology
#1,731
of 17,601 outputs
Outputs of similar age
#91,106
of 420,173 outputs
Outputs of similar age from Frontiers in Pharmacology
#84
of 640 outputs
Altmetric has tracked 23,929,753 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 17,601 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 420,173 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 640 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.